University of Palermo
Also known as: A.O.U. Policlinico "Paolo Giaccone" | AOU Policlinico "P. Giaccone" - University of Palermo, Italy | A.O.U.P. Paolo Giaccone Palermo | AOUP Paolo Giaccone, Palermo | A.O.V. Cervello - Palermo | Aurelio Seidita | Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo | Casa di Cura La Maddalena - Palermo | Centro di Riferimento Regionale Malattie Extra Piramidali, Palermo | D. Biological, Chemical and Pharmaceutical Sciences and Technologies, Palermo University | Faculty of Sport and Physical Education, University of Palermo | Hematology Unit- University of Palermo | Internal Medicine and Stroke Care Ward, University of Palermo, Italy | Internal Medicine, 'Giovanni Paolo II' Hospital of Sciacca (Agrigento) and University of Palermo, Palermo, Italy | Internal Medicine, Giovanni Paolo II Hospital of Sciacca (Agrigento) and University of Palermo, Palermo, Italy | Napolitano Mariasanta | Sezione di Gastroenterologia, Di.Bi.M.I.S. University of PALERMO, ITALY | Università degli Studi di Palermo | University Hospital of Palermo | University Hospital of Palermo, Italy | University Hospital of Palermo, Palermo, Italy | University of Palermo | University of Palermo, Di.Chir.On.S | University of Palermo - Italy | University of Palermo, Italy | UO Universita degi Studi Policinico Ematologia
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1999Last known activity
Jun 30, 2025
Timeline
1800s
- Jan 1, 1806
University of Palermo— Founded
Drugs by trial phase (63 distinct, 53 trials)
Phase 4 (27 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Other trials (19 own, 0 via acquisition)
Indications
Studied for
- ACTH-Secreting Pituitary Adenoma
- Amyotrophic Lateral Sclerosis
- Ascites
- Carcinoma, Non-Small-Cell Lung
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Embolism
- Fatty Liver
- Fatty Liver, Alcoholic
- Fibrosis
- Heart Failure
- Hepatitis
- Hepatitis, Chronic
- Ischemia
- Leukemia
- Leukemia, Lymphoid
- Liver Diseases
- Lung Neoplasms
- Lymphoma
- Motor Neuron Disease
- Non-alcoholic Fatty Liver Disease
- Parkinson Disease
- Pituitary ACTH Hypersecretion
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Pulmonary Embolism
- Sclerosis
- Stroke
- Thrombocytopenia
- Thrombosis
- Venous Thrombosis
Recent trials (50)
- NCT06985186Sponsor investigatorPhase 4Jun 30, 2025
- NCT06985186Lead sponsorPhase 4Jun 30, 2025
- NCT06449339CollaboratorPhase 4Jul 17, 2024
- NCT06442280Lead sponsorPhase 4Jun 30, 2024
- NCT06442280Sponsor investigatorPhase 4Jun 30, 2024
- NCT06442280OfficialPhase 4Jun 30, 2024
- NCT06314126Lead sponsorN/AJan 1, 2024
- NCT06314126OfficialN/AJan 1, 2024
- NCT06314126Sponsor investigatorN/AJan 1, 2024
- NCT06125626Lead sponsorPhase 2Jul 10, 2023
- NCT06125626Reponsible party - principal investigatorPhase 2Jul 10, 2023
- NCT06656871Sponsor investigatorN/AJun 10, 2023
- NCT06656871Lead sponsorN/AJun 10, 2023
- NCT06316206Sponsor investigatorPhase 4Jan 1, 2023
- NCT06316180Sponsor investigatorPhase 4Jan 1, 2023
Details
- Founded
- Palermo, IT Jan 1, 1806
- Last known activity
- Jun 30, 2025